{
	"type": "rich",
	"version": "1.0",
	"provider_name": "Action Network",
	"provider_url": "https://actionnetwork.org",
	
	"html": "<link href='https://actionnetwork.org/css/style-embed-v3.css' rel='stylesheet' type='text/css' /><script src='https://actionnetwork.org/widgets/v6/letter/tell-president-napolitano-make-xtandi-accessible?format=js&source=widget'></script><div id='can-letter-area-tell-president-napolitano-make-xtandi-accessible' style='width: 100%'><!-- this div is the target for our HTML insertion --></div>",
	"author_name": "UAEM",
	"author_url": "https://actionnetwork.org/groups/uaem",
	"title": "Tell President Napolitano: Make Xtandi Accessible",
	"thumbnail_url": "https://can2-prod.s3.amazonaws.com/groups/default_facebook_images/000/049/658/original/DSCF0758.JPG?1683578290",
	"description": "The University of California is complicit in keeping a medicine priced out of reach of those who need it most. Write to UC President Janet Napolitano today to demand that the university live up to its social mission and make sure medicines developed on campus are affordable and accessible. In March 2016, UCLA sold its royalty interests on three patents it held on this drug to Royalty Pharma for $1.14 billion, with almost half of this figure going back to the university.  This life-saving prostate cancer drug was developed at UCLA with the support of grants from the National Institutes of Health and Department of Defense. Despite this, the drug is being sold at $147,000 per year per patient, which is more than two to four times the prices in other high income, high GDP countries including Canada and the UK. Further, UCLA filed a patent claim with Delhi High Court, that could prevent the introduction of a more affordable generic competitor. Lives are at stake and UCLA can and must live up to its mission as a public research university. That mission is “the creation, dissemination, preservation and application of knowledge for the betterment of our global society.” If discoveries made at UCLA with public funding are priced out of the reach of ordinary people, they do not contribute to this lofty mission and they force American taxpayers to instead pay with their lives. By filing this patent claim, UCLA is actively complicit in creating access barriers that are causing harm to prostate cancer patients worldwide.",
	"url": "https://actionnetwork.org/letters/tell-president-napolitano-make-xtandi-accessible"
}